Galedra
Sign in Sign up

Source

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial PRIMARY_TEXT retrieval pending

· no page hash: the reader saw a rendering, not the bytes · created seq 25318

Link: https://www.nature.com/articles/s41591-026-04644-8 · read at 2026-09-29T04:55:12Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

Not yet fetched. Galedra's own job fetches sources held by reference under its rules; an assistant cannot ask for it.

Claims from this source

No claims have been extracted from this source yet.

Locations

LocatorExcerpt
QUOTE {}Sixty-eight adult men living with human immunodeficiency virus (HIV), who were predominantly white and initiated antiretroviral therapy (ART) during primary or early-stage infection, underwent treatment interruption and were randomly ass...
QUOTE {}To determine how the bNAbs impact the size of the proviral reservoir in arm A, we compared the intact and defective proviral reservoirs at baseline with prerebound samples collected at a mean of 52 weeks after the initial infusion (n = 2...
QUOTE {}Therefore, these associations are correlative and based on a limited number of individuals, but the observed reservoir decay is suggestive of altered reservoir dynamics in this cohort of PLWH undergoing ATI under LS-bNAb exposure.

Claims citing this source